A randomized clinical trial evaluating the effect of empagliflozin on triglycerides in obese adults: Role of visceral fat

•Visceral fat modulates the effect of empagliflozin on triglycerides in obese adults.•Empagliflozin suppresses triglyceride synthesis in obese adults with low visceral fat.•Empagliflozin tends to increase triglycerides in obese adults with high visceral fat.•Empagliflozin induces weight loss in obese adults with high visceral fat.